Gilead Sciences, Inc. (NASDAQ:GILD) is one of the 10 Best Value Stocks to Buy According to Billionaires. The company ...

Despite highly effective HIV prevention drugs on the market, only a fraction of those at risk in the U.S. are taking them — or even know they're an option. It's called pre-exposure prophylaxis ...

The US FDA has approved lenacapvir, sold under the brand name Yeztugo, as the first preventive treatment against HIV. It is a twice-yearly injectable drug developed for adults and teenagers.

HIV pre-exposure prophylaxis (PrEP) with daily oral tenofovir disoproxil fumarate (TDF) or TDF–emtricitabine (FTC) has been shown to be effective against sexual and injection-drug related HIV ...

A drug called lenacapavir, administered in two injections a year, offers protection from HIV comparable to daily pills. One ...

Pre-Exposure Prophylaxis (PrEP) is an HIV prevention strategy that enables HIV-negative people to stay HIV-negative by taking anti-HIV drugs (also called antiretrovirals, or "ARVs") before they are ...

The Food and Drug Administration has approved a highly effective new HIV-prevention medication, Gilead Sciences reported Wednesday. In clinical trials, the drug nearly eliminated HIV’s spread among ...

A brand new drug might be more effective at preventing HIV than current methods. Many people take daily oral antiretroviral medication—known as PrEP (pre-exposure prophylaxis)—to protect ...

“This is a historic day in the decades-long fight against HIV,” Gilead CEO Daniel O’Day said in the company’s announcement. “Yeztugo is one of the most important scientific breakthroughs of our time ...

The U.S. Food and Drug Administration (FDA) on June 18 approved a newly developed HIV/AIDS prevention drug that only needs to ...

pre-exposure prophylaxis. Health / 5 March 2025. ... Popping into your local pharmacy for anti-HIV pills and jabs could help slow new infections. So why is it not allowed in SA?